Investor profile
Quaker Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Quaker Partners is an East Coast-focused healthcare investment firm that pursues a traditional venture capital strategy, leading equity investments in healthcare companies at all stages of development. The firm invests across a diverse range of healthcare subsectors, including biotech, pharmaceuticals, medical devices, clinical diagnostics, health platforms, telemedicine, and digital health. Their investment strategy emphasizes identifying and supporting companies that are commercializing innovative products and technologies aimed at improving patient outcomes. The firm manages over $700 million in committed capital and provides strategic guidance while leveraging their extensive network of healthcare professionals and investors to enhance portfolio company growth.
Notable quotes
“The way we think of it now is we are consciously diversified among four major sectors in healthcare. The sectors are pharmaceuticals, which includes biotechnology; medical devices; clinical diagnostics and life-sciences tools; and health-care services.”
“I don't want to say [Quaker's second fund] is a later-stage fund, because it's not, but it's more balanced with a good sampling of later-stage investments.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Neuronetics | IPO | — | 2018-06-28 |
| TELA Bio | IPO | — | 2019-11-08 |
| Rapid Micro Biosystems | IPO | — | 2021-07-15 |
| Intact Vascular | unknown | — | — |
| Vesper Medical | unknown | — | — |
| Tarsa Therapeutics | unknown | — | — |
| Amicus Therapeutics | unknown | — | — |
| Insmed | unknown | — | — |
Fit check
Is Quaker Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit